DUBLIN--(BUSINESS WIRE)--The "Global Pharmaceutical Fine Chemicals Category - Procurement Market Intelligence Report" report has been added to ResearchAndMarkets.com's offering.
Procurement research report on the pharmaceutical fine chemicals market provides procurement professionals with up-to-date information about market shifts and potential risks, as well as in-depth knowledge of products and services. This report provides a detailed analysis of the supply market, procurement challenges, and procurement best practices, which can help in planning and executing category management activities. It also focuses on the cost-saving aspects of procurement and on providing insights that can lead to optimization of category spend.
One of the primary drivers of the pharmaceuticals fine chemicals industry is the increase in drug product approvals in the US by the FDA and in the EU by the EMA. Drug approval is a new opportunity for pharmaceutical fine chemicals manufacturers as pharmaceutical fine chemicals are used as raw materials in the drug formulation process. Furthermore, new drug approvals and patent cliff are leading to the bulk production of several drugs. This, in turn, will be a direct driver for the pharmaceutical fine chemicals industry.
One of the procurement best practices for buyers is to adopt measures to enhance visibility over the supply chain. Buyers need to adopt systems and practices that can improve their visibility over the entire supply chain by utilizing digital systems such as QMS, CRM, SCM, and ERP. These digital systems combined with analytical tools can ensure seamless flow of information and provide traceability and visibility across the supply chain.
Key Topics Covered:
Part 1: Category At A Glance
Part 2: Scope Of The Report
Part 3: Market Insights
Part 4: Supply Market Insights
Part 5: Pricing Insights
Part 6: Procurement Insights
Part 7: Top Five Suppliers
- Boehringer Ingelheim
For more information about this report visit https://www.researchandmarkets.com/research/kdv43c/global?w=4